Main menu button

News

Equity research Viva Wine Group Q2 2026: Margin relief in a soft market
21 Aug 2026
Equity research Viva Wine Group Q2 2026: Margin relief in a soft market
Equity Research Viva Wine Group
Equity research Angler Gaming, Q2 2026: Growth confirmed, margins at new highs
21 Aug 2026
Equity research Angler Gaming, Q2 2026: Growth confirmed, margins at new highs
Equity Research Angler Gaming
Equity research Angler Gaming, Q2 2026: Revenue and EBIT beat
20 Aug 2026
Equity research Angler Gaming, Q2 2026: Revenue and EBIT beat
Equity Research Angler Gaming
Equity research Viva Wine Group Q2 2026: First impression - EBITA beat despite soft organic growth
20 Aug 2026
Equity research Viva Wine Group Q2 2026: First impression - EBITA beat despite soft organic growth
Equity Research Viva Wine Group
Equity research Pila Pharma: Receives go-ahead for start of obesity trials
18 Aug 2026
Equity research Pila Pharma: Receives go-ahead for start of obesity trials
Equity Research Pila Pharma
Analys Elicera Therapeutics: Lovande data från upploppet av CARMA-studiens första del
11 Aug 2026
Analys Elicera Therapeutics: Lovande data från upploppet av CARMA-studiens första del
Equity Research Elicera Therapeutics
Equity research Immunovia, Q2 2026: MediCare submission and partnerships in focus
07 Aug 2026
Equity research Immunovia, Q2 2026: MediCare submission and partnerships in focus
Equity Research Immunovia
Equity Research ALM Equity, Q2 2026: Revenue is expected to increase during H2 2026
17 Jul 2026
Equity Research ALM Equity, Q2 2026: Revenue is expected to increase during H2 2026
Equity Research ALM Equity
Equity Research ALM Equity, Q2 2026: The significant increase in Klövern shares boosted earnings
16 Jul 2026
Equity Research ALM Equity, Q2 2026: The significant increase in Klövern shares boosted earnings
Equity Research ALM Equity
Equity research CDON, Q2 2026: GMV leads, profits should follow
16 Jul 2026
Equity research CDON, Q2 2026: GMV leads, profits should follow
Equity Research CDON
Equity research CDON Q2 2026: First impression - Solid GMV while growth investments weigh on margins
15 Jul 2026
Equity research CDON Q2 2026: First impression - Solid GMV while growth investments weigh on margins
Equity Research CDON
Equity Research KlaraBo, Q2 2026: Income from property management is rising again
13 Jul 2026
Equity Research KlaraBo, Q2 2026: Income from property management is rising again
Equity Research KlaraBo
Equity research Zinzino: Preview Q2 2026 - Tepid growth with margin expansion
10 Jul 2026
Equity research Zinzino: Preview Q2 2026 - Tepid growth with margin expansion
Equity Research Zinzino
Equity Research KlaraBo, Q2 2026: Income from property management was as expected
10 Jul 2026
Equity Research KlaraBo, Q2 2026: Income from property management was as expected
Equity Research KlaraBo
Equity research Viva Wine Group: Preview Q2 2026 - Takeout offer amid a slowdown
08 Jul 2026
Equity research Viva Wine Group: Preview Q2 2026 - Takeout offer amid a slowdown
Equity Research Viva Wine Group
Equity research CDON AB: Preview Q2 2026 - Sowing the seeds of profitable growth
06 Jul 2026
Equity research CDON AB: Preview Q2 2026 - Sowing the seeds of profitable growth
Equity Research CDON
Equity Research ALM Equity, Q2 2026: An increased pace in the construction sector
06 Jul 2026
Equity Research ALM Equity, Q2 2026: An increased pace in the construction sector
Equity Research ALM Equity
Equity Research Viva Wine Group: Key shareholders launch SEK 38.5 per share cash takeout offer
29 Jun 2026
Equity Research Viva Wine Group: Key shareholders launch SEK 38.5 per share cash takeout offer
Equity Research Viva Wine Group
Equity Research KlaraBo, Q2 2026: 7% estimated growth in income from property management
29 Jun 2026
Equity Research KlaraBo, Q2 2026: 7% estimated growth in income from property management
Equity Research KlaraBo
Equity reseach Pila Pharma: Sizing up a small molecule in obesity
03 Jun 2026
Equity reseach Pila Pharma: Sizing up a small molecule in obesity
Equity Research Pila Pharma